Novavax reported $59.56M in Trade Creditors for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Adamas Pharmaceuticals ADMS:US 4.21M 1.74M
Adma Biologics ADMA:US $ 17.28M 11.12M
Dynavax Technologies DVAX:US $ 3.6M 8.48M
Genocea Biosciences GNCA:US $ 0.98M 0.38M
Geron GERN:US $ 4.71M 0.96M
Kindred Biosciences KIN:US 926K 573K
Mannkind MNKD:US $ 9.53M 2.04M
Minerva Neurosciences NERV:US $ 1.2M 0.39M
Moderna Inc MRNA:US 87M 10M
Novartis NVS:US $ 4665M 146M
Novavax NVAX:US $ 59.56M 14.43M
Pain Therapeutics PTIE:US $ 2.34M 433K
Peregrine Pharmaceuticals PPHM:US $ 9.61M 0.35M
Sarepta Therapeutics SRPT:US $ 44.16M 32.52M